KRAS and neoplasm: While KRAS-mutated tumours displayed decreased immune cell infiltration compared to KRAS wild-type tumours, the opposite was found for BRAF-mutated tumours, differences that were most obvious for the cytotoxic T cells and the Th1 cells.